People · Operator
Named in public records as an officer, director or promoter · active 2011–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Hera Testing Laboratories, Inc. | — | Biotechnology | Seed | $3.4M | $45.4M | 2015 |
| Vindico NanoBioTechnology, Inc. | — | Biotechnology | Seed | $1.3M | $57.1M | 2015 |
| Transposagen Biopharmaceuticals, Inc. | — | Biotechnology | Pre-Seed | $1.1M | $19.6M | 2011 |
Eric M Ostertag at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Eric M Ostertag on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Christopher H. Young | 1 | 2 |
| Paiman Peter Ghoroghchian | 1 | 2 |
| Eric H. Ostertag | 1 | 1 |
| Michael J. Schlosser | 1 | 1 |
| Thomas M Isett | 1 | 1 |
| Christopher M Young | 1 | 1 |
| Joseph M. Ruiz | 1 | 1 |
| Jack M Crawford | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.